GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (BOM:524470) » Definitions » Net Margin %

Syncom Formulation (India) (BOM:524470) Net Margin % : 10.75% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Syncom Formulation (India) Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Syncom Formulation (India)'s Net Income for the three months ended in Dec. 2023 was ₹70 Mil. Syncom Formulation (India)'s Revenue for the three months ended in Dec. 2023 was ₹651 Mil. Therefore, Syncom Formulation (India)'s net margin for the quarter that ended in Dec. 2023 was 10.75%.

The historical rank and industry rank for Syncom Formulation (India)'s Net Margin % or its related term are showing as below:

BOM:524470' s Net Margin % Range Over the Past 10 Years
Min: 5.61   Med: 6.13   Max: 12.19
Current: 10.64


BOM:524470's Net Margin % is ranked better than
71.18% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 3.27 vs BOM:524470: 10.64

Syncom Formulation (India) Net Margin % Historical Data

The historical data trend for Syncom Formulation (India)'s Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) Net Margin % Chart

Syncom Formulation (India) Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.09 7.12 12.19 9.09 9.02

Syncom Formulation (India) Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.22 14.31 7.35 10.20 10.75

Competitive Comparison of Syncom Formulation (India)'s Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syncom Formulation (India)'s Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s Net Margin % distribution charts can be found below:

* The bar in red indicates where Syncom Formulation (India)'s Net Margin % falls into.



Syncom Formulation (India) Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Syncom Formulation (India)'s Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin=Net Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=200.707/2224.861
=9.02 %

Syncom Formulation (India)'s Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=70.017/651.395
=10.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syncom Formulation (India)  (BOM:524470) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Syncom Formulation (India) Net Margin % Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Syncom Formulation (India) (BOM:524470) Business Description

Traded in Other Exchanges
Address
207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) (BOM:524470) Headlines

No Headlines